Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android. Learn more here!

Inborn error of metabolism affecting the mitochondrial catabolism of valine and isoleucine untreated resulting in ketoacidosis, lethargy, coma, and, finally, death.

Propionic Aciduria; Ketotic Hyperglycinemia; Hyperglycinemia with Ketoacidosis and Leukopenia; Propionyl-CoA Carboxylase Deficiency.

First described in 1961 by B. Childs, an American pediatrician.

Approximately 1:100,000 live births with both genders equally affected. Incidences as high as 1:2000 to 1:5000 live births have been reported from Saudi Arabia.

Autosomal recessive. The enzyme is composed of two independently encoded enzyme subunits, an α subunit encoded on chromosome 13 and a β subunit encoded on chromosome 3. Biotin is a cofactor and binds to the α subunit. Two distinct genotypes can be identified by cell complementation: PCCA (propionyl-CoA carboxylase A) resulting in a defect of the α subunit and PCCB (propionyl-CoA carboxylase B) in a defect of the β subunit. A defect in the synthesis or function of biotin (deficiency of biotinidase, which is responsible for the cleaving of biotin from biocytin), or a deficiency of holocarboxylase synthetase (biotin-methylcrotonyl-CoA-carboxylase ligase), which catalyzes the incorporation of biotin into apo-carboxylases) can, however, lead to a similar clinical picture.

The mutation results in a defect in the mitochondrial enzyme propionyl-CoA carboxylase. This enzyme is responsible for the generation of methylmalonyl-CoA from propionyl-CoA, which derives from the catabolism of essential amino acids such as isoleucine, valine, methionine, and threonine, as well as from odd-chain fatty acids and cholesterol. Accumulation of propionyl-CoA results in inhibitory effects on various pathways of intermediary mitochondrial metabolism and secondary carnitine deficiency. The appearance of increased levels of long, odd-chain fatty acids may be related to the increased concentration of propionyl-CoA, which is a primer for these compounds. Ketoacidosis develops secondary to inhibition of the citric acid cycle enzymes by propionic acid. Propionyl-CoA is split in coenzyme-A and propionic acid, which contributes to the metabolic acidosis. Decreased ureagenesis and hyperammonemia seem to be secondary to inhibition of mitochondrial carbamyl phosphate synthetase (CPS) by intramitochondrial accumulation of organic acids and CoA-esters caused by the defect in propionyl-CoA carboxylase. Furthermore, increased concentration of propionate results in decreased levels of hepatic N-acetyl-glutamate, which is an allosteric effector for CPS. In contrast, hyperglycinemia may be nonspecific because it can also be found in other conditions in children with negative nitrogen balance. Moreover, anaerobic fermentation of odd-chain fatty acids in the GI tract also yields propionic acid.

Made by clinical presentation and organic aciduria with high levels of propionic acid, methylcitrate, and tiglylglycine. Tiglylglycine is an intermediate product of the catabolism of isoleucine. It is a potential marker of disorders of the respiratory chains. Cultured fibroblasts are used to analyze the enzyme activity. However, propionyl-CoA carboxylase activity does not necessarily correlate with the clinical picture, because there are (unexplained) case reports with almost absent enzyme activity but no clinical symptoms. Measuring propionyl-CoA carboxylase activity in cultured amniotic cells or chorionic villous biopsies allows for prenatal ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.